4.7 Article

Advances in Antioxidant Nanomedicines for Imaging and Therapy of Alzheimer's Disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Nanoscience & Nanotechnology

Gold Nanorods with Spatial Separation of CeO2 Deposition for Plasmonic-Enhanced Antioxidant Stress and Photothermal Therapy of Alzheimer's Disease

Kezhen Ge et al.

Summary: This study explored the application of ceria nanoparticles in the treatment of Alzheimer's disease (AD). By introducing photothermal effect and photocatalytic activity, the treatment efficacy was improved. Biocompatibility and therapeutic effectiveness of Aβ-targeted inhibitory peptide-modified nanocomposites were verified in vitro and in vivo, suggesting the significant potential of nanotechnology in AD therapy.

ACS APPLIED MATERIALS & INTERFACES (2022)

Article Chemistry, Multidisciplinary

Liposome delivery to the brain with rapid short-pulses of focused ultrasound and microbubbles

Sophie Morse et al.

Summary: The study investigates a noninvasive method of using ultrasound pulses to deliver liposomes across the blood-brain barrier for efficient drug delivery to the brain.

JOURNAL OF CONTROLLED RELEASE (2022)

Article Biochemistry & Molecular Biology

Impacts of oxidants and antioxidants on the emergence and progression of Alzheimer's disease

Hamieh Goshtasbi et al.

Summary: The brain is highly sensitive to oxidative stress, and maintaining a balance between oxidants and antioxidants is crucial for its normal function. Imbalance between reactive oxygen species (ROS) and cellular mechanisms can lead to neurodegenerative disorders. Nuclear factor erythroid 2-related factor 2 (NRF2) is a key transcription factor that regulates the expression of antioxidant genes in response to oxidative stress. This review focuses on the mechanisms of generation of endogenous and exogenous oxidants and the role of antioxidants in neural cells through the NRF2-ARE signaling pathway.

NEUROCHEMISTRY INTERNATIONAL (2022)

Review Biochemistry & Molecular Biology

A Leaky Blood-Brain Barrier to Fibrinogen Contributes to Oxidative Damage in Alzheimer's Disease

James G. McLarnon

Summary: The disruption of the blood-brain barrier in Alzheimer's disease leads to the extravasation of plasma protein fibrinogen into the brain, causing immune reactivity and inflammation. Abnormal aggregation of fibrinogen, interaction with immune cells, and the production of neurotoxic reactive oxygen species contribute to neuronal and synaptic damage in AD.

ANTIOXIDANTS (2022)

Review Biochemistry & Molecular Biology

Naturally Occurring Antioxidant Therapy in Alzheimer's Disease

Andrila E. Collins et al.

Summary: The prevalence of Alzheimer's disease is estimated to double by 2040. Current treatments do not address the underlying causes of the disease, but research suggests that antioxidants may help mitigate oxidative stress. Recent studies have focused on natural antioxidants as potential preventatives and treatments for neurodegenerative conditions associated with oxidative stress.

ANTIOXIDANTS (2022)

Article Chemistry, Analytical

Detection of Aβ oligomers in early Alzheimer's disease diagnose by in vivo NIR-II fluorescence imaging

Hengde Li et al.

Summary: This study reports a novel functional probe that responds to A beta oligomers, the biomarkers of early-stage Alzheimer's disease (AD), through near-infrared window (NIR-II) fluorescence imaging. The probe has high selectivity, preferentially targeting A beta oligomers and readily crossing the blood-brain barrier.

SENSORS AND ACTUATORS B-CHEMICAL (2022)

Article Medicine, Research & Experimental

Design and Validation of Liposomal ApoE2 Gene Delivery System to Evade Blood-Brain Barrier for Effective Treatment of Alzheimer's Disease

Sanjay Arora et al.

Summary: This study demonstrated efficient brain-targeted delivery of ApoE2 gene therapy using surface-modified liposomes, with significantly higher ApoE2 expression in neurons and potential for effective AD treatment.

MOLECULAR PHARMACEUTICS (2021)

Article Cell Biology

Transferrin-Pep63-liposomes accelerate the clearance of Aβ and rescue impaired synaptic plasticity in early Alzheimer's disease models

Xiu Yang et al.

Summary: Alzheimer's disease (AD) is characterized by the accumulation of extracellular beta-amyloid (A beta) peptides in the brain. A novel liposome delivery system, transferrin-Pep63-liposomes (Tf-Pep63-Lip), was developed to target A beta oligomers and fibrils, reducing A beta burden and improving cognitive deficits in mouse models. Additionally, Tf-Pep63-Lip exhibited neuroprotective effects by inhibiting A beta aggregation and disaggregation, as well as promoting microglial chemotaxis for clearance.

CELL DEATH DISCOVERY (2021)

Article Engineering, Biomedical

Reactive-oxygen-species-scavenging nanomaterials for resolving inflammation

X. Huang et al.

Summary: ROS can mediate various physiological functions, but their over-accumulation can lead to premature aging or death, as well as inflammatory conditions. Advances in nanoscience have led to the development of nanomaterials with unique ROS-scavenging abilities, allowing for the emergence of next-generation strategies to ameliorate ROS-related inflammatory conditions. Ongoing studies and clinical applications of nanomedicine based on ROS scavenging stand to benefit from this interdisciplinary field.

MATERIALS TODAY BIO (2021)

Article Nanoscience & Nanotechnology

Functional Gallic Acid-Based Dendrimers as Synthetic Nanotools to Remodel Amyloid-β-42 into Noncytotoxic Forms

Ana R. Araujo et al.

Summary: In this study, the synthesis of nanosized, functional gallic acid-based dendrimers is described, which interact with Aβ species and remodel them into noncytotoxic aggregates. The multivalent presentation of gallic acid on the dendrimer surface enhances their ability to interact with Aβ, inhibiting fibrillization and disrupting preformed fibrils.

ACS APPLIED MATERIALS & INTERFACES (2021)

Review Engineering, Biomedical

Photoresponsive materials for intensified modulation of Alzheimer's amyloid-β protein aggregation: A review

Wei Liu et al.

Summary: The review discusses the recent advances in modulating A beta aggregation through light irradiation, particularly focusing on photothermal and photodynamic therapy as well as photoresponsive drug release systems. These approaches enhance drug efficacy and avoid adverse effects, offering promising prospects for AD treatment.

ACTA BIOMATERIALIA (2021)

Article Chemistry, Analytical

Multifunctional Metal-Organic Framework as a Versatile Nanoplatform for Aβ Oligomer Imaging and Chemo-Photothermal Treatment in Living Cells

Xueyan Yan et al.

Summary: This study successfully synthesized a multifunctional nanocomposite that can be used for detecting and treating Alzheimer's disease, releasing drugs upon near-infrared irradiation, inhibiting amyloid aggregation and degrading fibrils, as well as alleviating amyloid-induced oxidative stress and neural apoptosis.

ANALYTICAL CHEMISTRY (2021)

Article Engineering, Biomedical

Microbubbles Containing Lysolipid Enhance Ultrasound-Mediated Blood-Brain Barrier Breakdown In Vivo

Oliver Vince et al.

Summary: The study shows that a new formulation of microbubbles containing lysolipids can enhance blood-brain barrier permeability, leading to approximately twofold increase at the highest ultrasound pressure. This modification has the potential to improve drug delivery deep within the brain without the need to increase ultrasound pressure amplitude.

ADVANCED HEALTHCARE MATERIALS (2021)

Article Chemistry, Multidisciplinary

In Vivo Brain Imaging of Amyloid-β Aggregates in Alzheimer's Disease with a Near-Infrared Fluorescent Probe

Jian Wu et al.

Summary: This study introduces a novel near-infrared fluorescent probe named CAQ for selective monitoring of A beta aggregates in vivo, which shows promise in providing comprehensive information for neurodegenerative disease research, promoting a deeper understanding of Alzheimer's pathological processes.

ACS SENSORS (2021)

Article Cell Biology

The emerging role of exosomes in Alzheimer's disease

Tongmei Zhang et al.

Summary: Exosomes, as potential biomarkers and therapeutic targets, play important roles in the pathogenesis, diagnosis, and treatment of Alzheimer's disease. Research findings suggest that exosomal constituents regulate intercellular communication and may offer new avenues for future AD treatments.

AGEING RESEARCH REVIEWS (2021)

Review Medicine, Research & Experimental

A Review of Brain-Targeted Nonviral Gene-Based Therapies for the Treatment of Alzheimer's Disease

Sanjay Arora et al.

Summary: Alzheimer's disease is a progressive and incurable CNS disorder characterized by the accumulation of A beta plaques and NFTs, as well as synaptic loss and neuronal signaling imbalance. Current treatments aim to manage symptoms and maintain cognitive functions while slowing down memory loss. Nonviral gene therapy shows promise in addressing these challenges, with advancements in technology offering potential solutions in clinical trials.

MOLECULAR PHARMACEUTICS (2021)

Article Chemistry, Analytical

Amyloid-β oligomer targeted theranostic probes for in vivo NIR imaging and inhibition of self-aggregation and amyloid-β induced ROS generation

Xueli Wang et al.

Summary: Novel near infrared emissive fluorophores exhibit strong selectivity towards Aβ oligomers and monomers, good biocompatibility and stability, and significant inhibitory effects on Aβ aggregation.

TALANTA (2021)

Article Neurosciences

Quercetin-Conjugated Superparamagnetic Iron Oxide Nanoparticles Protect AlCl3-Induced Neurotoxicity in a Rat Model of Alzheimer's Disease via Antioxidant Genes, APP Gene, and miRNA-101

Elnaz Amanzadeh Jajin et al.

Summary: The study suggests that quercetin-conjugated superparamagnetic iron oxide nanoparticles (QT-SPIONs) have a better neuroprotective effect on Alzheimer's disease than free quercetin, by regulating antioxidant, apoptotic, and gene expression levels. QT-SPIONs also show potential in reversing the symptoms of AD by maintaining the balance of antioxidant enzymes.

FRONTIERS IN NEUROSCIENCE (2021)

Review Chemistry, Multidisciplinary

Current Strategies for Modulating Aβ Aggregation with Multifunctional Agents

Zhi Du et al.

Summary: This article discusses the progress in the research field of Alzheimer's disease (AD), focusing on various methods and mechanisms for regulating amyloid-beta (A beta) aggregation, as well as the development of multifunctional therapeutic drugs and nanoparticles for comprehensive treatment of AD.

ACCOUNTS OF CHEMICAL RESEARCH (2021)

Article Nanoscience & Nanotechnology

Multimodal Theranostic Cyanine-Conjugated Gadolinium(III) Complex for In Vivo Imaging of Amyloid-β in an Alzheimer's Disease Mouse Model

Xueli Wang et al.

Summary: The developed Gd(DOTA)-cyanine dyad is the first imaging probe targeting Aβ that can be applied for one- and two-photon excited fluorescence and magnetic resonance imaging in AD mouse models. It possesses various desirable properties such as good biocompatibility, high Aβ selectivity, strong fluorescence enhancement, and inhibition of Aβ aggregation and toxicity. This theranostic probe shows promise for diagnosis and therapy of AD and has potential for MRI imaging of Aβ in humans.

ACS APPLIED MATERIALS & INTERFACES (2021)

Article Biochemistry & Molecular Biology

Curcumin and Homotaurine Suppress Amyloid-β25-35 Aggregation in Synthetic Brain Membranes

Xingyuan Zou et al.

Summary: The study found that curcumin and homotaurine can effectively reduce the aggregation of amyloid beta and have no observable impact on brain membranes. These drugs inhibit A beta aggregation by changing membrane properties and binding to A beta peptides. Membrane-lipid therapy may be an effective approach to inhibit peptide aggregation.

ACS CHEMICAL NEUROSCIENCE (2021)

Article Chemistry, Multidisciplinary

Biomimetic Dendrimer-Peptide Conjugates for Early Multi-Target Therapy of Alzheimer's Disease by Inflammatory Microenvironment Modulation

Peixin Liu et al.

Summary: Current therapeutic strategies for Alzheimer's disease mainly focus on beta-amyloid targeting, but limited outcomes are achieved due to chronic and irreversible nervous system impairment in late stage. A new nanoconjugate, APBP, designed to target early inflammatory responses, shows promising results in reducing ROS levels, decreasing A beta burden, alleviating glial cell activation, and enhancing cognitive functions in AD model mice.

ADVANCED MATERIALS (2021)

Article Pharmacology & Pharmacy

Large Amino Acid Mimicking Selenium-Doped Carbon Quantum Dots for Multi-Target Therapy of Alzheimer's Disease

Xi Zhou et al.

Summary: The selenium-doped carbon quantum dots (SeCQDs) are proposed as novel nanoagents for multi-target therapy of Alzheimer's disease (AD), as they possess dual functions of inhibiting Aβ aggregation and scavenging ROS. SeCQDs have good biocompatibility and antioxidant activity, with the ability to significantly improve Aβ-induced memory deficits and inhibit neuron degeneration.

FRONTIERS IN PHARMACOLOGY (2021)

Review Chemistry, Multidisciplinary

Physiological and Pathological Factors Affecting Drug Delivery to the Brain by Nanoparticles

Yamir Islam et al.

Summary: The prevalence of neurological/neurodegenerative diseases, such as Alzheimer's disease, is increasing due to an aging population, posing challenges for treatment as therapeutic agents struggle to reach the brain. Brain physiology changes during diseases and aging, potentially increasing blood-brain barrier permeability, making drug delivery to the diseased brain even more complex. New approaches using nanoparticles or magnetic resonance imaging guided systems have been discussed for delivering therapeutic agents to the brain, while also considering complement activation, toxicity, and immunogenicity of brain targeting nanoparticles.

ADVANCED SCIENCE (2021)

Article Medicine, General & Internal

Alzheimer disease

David S. Knopman et al.

Summary: Alzheimer's disease is a neurodegenerative disorder characterized by cognitive impairments. The pathophysiology involves a complex interplay of loss of synaptic homeostasis and dysfunction in endosomal/lysosomal clearance pathways. Therapeutic options are still being sought to substantially alter the clinical course of individuals with Alzheimer's disease.

NATURE REVIEWS DISEASE PRIMERS (2021)

Review Chemistry, Multidisciplinary

Reactive Oxygen Species-Based Nanomaterials for Cancer Therapy

Yingbo Li et al.

Summary: Advancements in nanotechnology for cancer therapy have led to the development of nanomaterials that specifically generate cytotoxic reactive oxygen species (ROS) in tumor cells. These materials disturb the redox balance in tumor cells, leading to oxidative damage of DNA and proteins.

FRONTIERS IN CHEMISTRY (2021)

Article Nanoscience & Nanotechnology

Natural Phyto-Antioxidant Albumin Nanoagents to Treat Advanced Alzheimer's Disease

Yan Dou et al.

Summary: The quercetin nanoparticles demonstrated excellent antioxidant and neuroprotective effects in treating advanced Alzheimer's disease, preventing oxidative stress, neuronal apoptosis, and cognitive impairment. They also showed promising biosafety and biocompatibility for future drug development and clinical applications.

ACS APPLIED MATERIALS & INTERFACES (2021)

Article Nanoscience & Nanotechnology

Multifunctional Selenium Quantum Dots for the Treatment of Alzheimer's Disease by Reducing Aβ-Neurotoxicity and Oxidative Stress and Alleviate Neuroinflammation

Xian Guo et al.

Summary: SeQDs, as a novel drug with multi-target therapeutic effects, show significant advantages in the treatment of Alzheimer's disease, including rapid penetration of the blood-brain barrier, inhibition of Aβ aggregation, reduction of tau protein phosphorylation, and reduction of oxidative stress, ultimately improving cognitive and memory abilities in AD patients.

ACS APPLIED MATERIALS & INTERFACES (2021)

Article Chemistry, Physical

Inhibition of Amyloid Aggregation and Toxicity with Janus Iron Oxide Nanoparticles

Nicholas Andrikopoulos et al.

Summary: Amyloid aggregation is a common pathology underlying various human diseases, including Alzheimer's disease, Parkinson's disease, and type 2 diabetes. Despite the challenges in treating these diseases, research has shown that synthesized nanoparticles can inhibit the aggregation of amyloid proteins and potentially offer therapeutic effects in animal experiments.

CHEMISTRY OF MATERIALS (2021)

Article Chemistry, Multidisciplinary

Novel concept of exosome-like liposomes for the treatment of Alzheimer's disease

Mario Fernandes et al.

Summary: Exosomes-like liposomes were developed for controlled delivery, efficiently encapsulating curcumin and showing potential neuroprotection without toxicity. These innovative carriers are stable, protect the cargo, and are uptaken by neuronal cells, offering a positive alternative strategy for Alzheimer's disease therapy.

JOURNAL OF CONTROLLED RELEASE (2021)

Article Chemistry, Multidisciplinary

Focused ultrasound with anti-pGlu3 Aβ enhances efficacy in Alzheimer's disease-like mice via recruitment of peripheral immune cells

Tao Sun et al.

Summary: The use of focused ultrasound (FUS) with microbubbles enhanced the delivery of an Fc-competent anti-pGlu3 Aβ monoclonal antibody to the brain, resulting in improved cognitive function and reduced plaque burden in aged Alzheimer's disease-like model mice. Additionally, the combination of antibody treatment with FUS-BBBD led to greater monocyte infiltration to plaques, suggesting a potential novel mechanism for enhancing immunotherapy efficacy in Alzheimer's disease.

JOURNAL OF CONTROLLED RELEASE (2021)

Article Chemistry, Multidisciplinary

Amphiphilic Distyrylbenzene Derivatives as Potential Therapeutic and Imaging Agents for Soluble and Insoluble Amyloid β Aggregates in Alzheimer's Disease

Liang Sun et al.

Summary: The development of the novel amphiphilic compound LS-4 significantly increases the binding affinity for various Aβ peptide aggregates, showing therapeutic potential for 5xFAD mice. The compound can penetrate the blood-brain barrier, reduce amyloid plaques and phosphorylated tau aggregates, and modulate microglia activation.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)

Article Neurosciences

PEGylated superparamagnetic iron oxide nanoparticles (SPIONs) ameliorate learning and memory deficit in a rat model of Alzheimer's disease: Potential participation of STIMs

Mehdi Sanati et al.

Summary: Low doses of SPIONs inhibit Aβ aggregation and ameliorate learning and memory deficits in the AD model, while also increasing hippocampal protein levels. However, at high doses, SPIONs do not improve the detrimental effects of Aβ aggregation on spatial memory and hippocampal protein expression.

NEUROTOXICOLOGY (2021)

Article Multidisciplinary Sciences

In vivo multi-parametric manganese-enhanced MRI for detecting amyloid plaques in rodent models of Alzheimer's disease

Eugene Kim et al.

Summary: The study found that manganese-enhanced MRI can visualize amyloid plaques in rodent models of AD, with the visibility of plaques in different brain regions varying depending on plaque size and iron load. Longitudinal relaxation rate mapping revealed increased manganese uptake in brain regions of high plaque burden in transgenic animals compared to their wild-type littermates.

SCIENTIFIC REPORTS (2021)

Review Materials Science, Biomaterials

Photothermal and Photodynamic Therapies via NIR-Activated Nanoagents in Combating Alzheimer's Disease

Fantian Zeng et al.

Summary: Phototherapy, using near-infrared-activated nanoagents, shows promise in treating Alzheimer's disease by modulating Aβ aggregation to restore nerve damage and improve memory deficits. Despite recent advances, challenges remain in improving the efficiency and utility of this treatment.

ACS BIOMATERIALS SCIENCE & ENGINEERING (2021)

Review Chemistry, Medicinal

Flavonoid-Based Nanomedicines in Alzheimer's Disease Therapeutics: Promises Made, a Long Way To Go

Pragya Prasanna et al.

Summary: Alzheimer's disease is characterized by cognitive decline due to the accumulation of amyloid-beta 42 and neurofibrillary tangles, and current treatment strategies focus on alleviating symptoms rather than providing a cure. Nanotechnology offers a promising approach for drug delivery to specific targets, and the combination of natural products and nanomedicine shows potential in AD treatment.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)

Article Medicine, Research & Experimental

Ultrasound-mediated augmented exosome release from astrocytes alleviates amyloid-beta-induced neurotoxicity

Zhiting Deng et al.

Summary: The study showed that ultrasound stimulation can enhance the release of exosomes from astrocytes, which have neuroprotective effects against Aβ toxicity. When combined with ultrasound-induced blood-brain-barrier opening, it enables the clearance of Aβ plaques in the brain.

THERANOSTICS (2021)

Review Instruments & Instrumentation

Nanotechnology to improve the Alzheimer's disease therapy with natural compounds

Maria Joao Ramalho et al.

DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2020)

Article Chemistry, Multidisciplinary

Amyloid-β Oligomer-Targeted Gadolinium-Based NIR/MR Dual-Modal Theranostic Nanoprobe for Alzheimer's Disease

Chengke Wang et al.

ADVANCED FUNCTIONAL MATERIALS (2020)

Article Nanoscience & Nanotechnology

Near-Infrared-Active Copper Bismuth Oxide Electrodes for Targeted Dissociation of Alzheimer's β-Amyloid Aggregates

Yerin Heo et al.

ACS APPLIED MATERIALS & INTERFACES (2020)

Article Pharmacology & Pharmacy

Quercetin lipid nanoparticles functionalized with transferrin for Alzheimer's disease

R. G. R. Pinheiro et al.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)

Article Biochemistry & Molecular Biology

High temperature promotes amyloid β-protein production and γ-secretase complex formation via Hsp90

Arshad Ali Noorani et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2020)

Article Medicine, Research & Experimental

Discovery of Diphenoxy Derivatives with Flexible Linkers as Ligands for β-Amyloid Plaques

Jianhua Jia et al.

MOLECULAR PHARMACEUTICS (2020)

Review Chemistry, Multidisciplinary

Redox-Responsive Nanobiomaterials-Based Therapeutics for Neurodegenerative Diseases

Despoina Eleftheriadou et al.

Article Multidisciplinary Sciences

Blood-brain barrier-penetrating siRNA nanomedicine for Alzheimer's disease therapy

Yutong Zhou et al.

SCIENCE ADVANCES (2020)

Article Chemistry, Medicinal

Intranasal Drug Delivery of Frovatriptan Succinate-Loaded Polymeric Nanoparticles for Brain Targeting

Deepika Deepika et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2019)

Review Chemistry, Multidisciplinary

Reactive Oxygen Species (ROS)-Based Nanomedicine

Bowen Yang et al.

CHEMICAL REVIEWS (2019)

Article Nanoscience & Nanotechnology

Cerium oxide NPs mitigate the amyloid formation of α-synuclein and associated cytotoxicity

Zahra Zand et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)

Article Engineering, Biomedical

Redox-Activated Near-Infrared-Responsive Polyoxometalates Used for Photothermal Treatment of Alzheimer's Disease

Mengmeng Ma et al.

ADVANCED HEALTHCARE MATERIALS (2018)

Review Biochemistry & Molecular Biology

Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer's Disease

Yu Yamazaki et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Article Acoustics

Blood-BrainBarrier Closure TimeAfter Controlled Ultrasound-Induced Opening Is Independent of Opening Volume

Meaghan A. O'Reilly et al.

JOURNAL OF ULTRASOUND IN MEDICINE (2017)

Review Medicine, Research & Experimental

Nucleic Acid-Based Theranostics for Tackling Alzheimer's Disease

Madhuri Chakravarthy et al.

THERANOSTICS (2017)

Article Chemistry, Multidisciplinary

Mitochondria-Targeting Ceria Nanoparticles as Antioxidants for Alzheimer's Disease

Hyek Jin Kwon et al.

ACS NANO (2016)

Review Medicine, Research & Experimental

The influence of common free radicals and antioxidants on development of Alzheimer's Disease

Karolina A. Wojtunik-Kulesza et al.

BIOMEDICINE & PHARMACOTHERAPY (2016)

Article Chemistry, Medicinal

From Companion Diagnostics to Theranostics: A New Avenue for Alzheimer's Disease?

Maria Laura Bolognesi et al.

JOURNAL OF MEDICINAL CHEMISTRY (2016)

Review Biotechnology & Applied Microbiology

Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases

Sara Hernando et al.

NANOMEDICINE (2016)

Article Biochemistry & Molecular Biology

Sialic Acid Hydroxamate: A Potential Antioxidant and Inhibitor of Metal-Induced -Amyloid Aggregates

Rohan Yadav et al.

CHEMBIOCHEM (2015)

Article Chemistry, Multidisciplinary

Gold-Nanoparticle-Based Multifunctional Amyloid-β Inhibitor against Alzheimer's Disease

Nan Gao et al.

CHEMISTRY-A EUROPEAN JOURNAL (2015)

Article Biochemistry & Molecular Biology

Nose-to-Brain Drug Delivery by Nanoparticles in the Treatment of Neurological Disorders

Wei-Yi Ong et al.

CURRENT MEDICINAL CHEMISTRY (2014)

Review Pharmacology & Pharmacy

Intranasal therapeutic strategies for management of Alzheimer's disease

Sumeet Sood et al.

JOURNAL OF DRUG TARGETING (2014)

Review Immunology

Regulation of immune responses by extracellular vesicles

Paul D. Robbins et al.

NATURE REVIEWS IMMUNOLOGY (2014)

Article Biochemistry & Molecular Biology

Glyconanoparticle Aided Detection of β-Amyloid by Magnetic Resonance Imaging and Attenuation of β-Amyloid Induced Cytotoxicity

Hovig Kouyoumdjian et al.

ACS CHEMICAL NEUROSCIENCE (2013)

Article Materials Science, Biomaterials

Amyloid-Binding Aptamer Conjugated Curcumin-PLGA Nanoparticle for Potential Use in Alzheimer's Disease

Anila Mathew et al.

BIONANOSCIENCE (2012)

Article Biochemistry & Molecular Biology

Small Molecule Fluorescent Probes for the Detection of Amyloid Self-Assembly In Vitro and In Vivo

Carlos W. Bertoncini et al.

CURRENT PROTEIN & PEPTIDE SCIENCE (2011)

Article Clinical Neurology

Blood-brain barrier permeability in Alzheimer's disease: a case-control MRI study

John M. Starr et al.

PSYCHIATRY RESEARCH-NEUROIMAGING (2009)